Sustaining longevity policy through research setbacks
Stolyarov proposes a lasting volunteer-supported political organization to pursue experimental treatment access and longevity research funding, but the source reports no enacted reform or allocated budget.
Political support for longevity research after unsuccessful trials
Gennady Stolyarov II, chairman of the U.S. Transhumanist Party, proposes a lasting political organization that would keep pursuing radical life extension when individual companies close and trials produce negative results. The organization would operate on a small budget through volunteer work, sustaining a long-term agenda for political change.
That agenda contains specific proposals. Stolyarov advocates broader access to experimental drugs, devices and treatments after early safety testing, before conventional efficacy trials are complete. He also proposes conditional drug approval after phase one trials, which primarily assess safety, followed by collecting evidence of benefit from patients receiving treatment. Under this approach, access to a drug would begin before its efficacy assessment is complete.
Two further proposals are to recognize aging as a medical indication, meaning a reason to provide treatment, and to allocate dedicated funding to longevity research. Stolyarov explains his political reasoning through the Overton window: the range of ideas the public and politicians consider acceptable to discuss. In his view, a radical goal makes smaller reforms look moderate and helps them enter the mainstream political agenda.
The material describes proposals. It reports no enacted reform, allocated budget or operating funding program. Stolyarov explains how political work could continue after company failures and unsuccessful trials; the source leaves open who would pay for the next study. It also establishes no connection between these proposals and Experiment, the organization whose page is linked below. This material gives us no basis to attribute funding for such research to Experiment.
Open the related Eternal Search page
Sources
[1] bostonlongevityweek.com
[2] youtube.com
This item was selected because it raises the concrete problem of sustaining research after company and trial failures; the linked Experiment record is relevant to that funding question, although the supplied evidence does not establish a specific connection or disclose its funding terms.